Most patients saw improvements in three critical measures of blood glucose control
Read More »Diabetes In Control
ADA: Once-Weekly BYETTA (Exenatide) LAR Improves Glucose Control in Patients wit
Reduces A1c by 2 points and average weight lose of 8 pounds in 15 weeks.
Read More »ADA: Short Term Economic Impact of Weight Change Among Patients with Type 2 Diab
A 1 percent weight loss was associated with a 5.6 percent decrease in health care costs, or approximately $408.
Read More »ADA: Encapsulated Human Islet Allografts in Type 1 Patients
Tirst two partially implanted patients are showing early evidence of encapsulated islet function.
Read More »ADA: Ten Thousand Patients Using Levemir Insulin Show Improvements in BG Without
Levemir reduced mean A1C levels by 0.54 percent for type 1 and 0.89 percent for type 2 diabetes patients.
Read More »Metformin Chewing Gum for Type-2 Diabetes and Obesity
It seems that chewing gum is a good method of drug delivery. Generex Biotechnology collaborates with medicinal chewing gum developer Fertin Pharma A/S to develop a chewing gum containing metformin, a generic drug used for the treatment of Type-2 diabetes mellitus and obesity.
Read More »Buffet Table Tips for People with Diabetes
Hand out for barbeque season. Barbecues, picnics and family reunions are gatherings to enjoy and treasure. If you have diabetes, these events can pose special challenges. How can you stick with your meal plan, yet join in the celebration and have some fun? Buffet Table Tips (pdf)
Read More »Mixing Long and Short Acting Insulins in Same Syringe Does Not Compromise Long-T
Mixing Lantus and rapid-acting insulins as Humalog or Novolog does not compromise glycemic control. Similar to what has been shown in short-term studies, rapid-acting insulin analogues (RAI) can be mixed with insulin glargine without compromising long-term glycemic control in children with type 1 diabetes, new research shows. The ability to …
Read More »Diabetes Prescriptions for Kids Doubled in 4 Years
First study to show the dramatic increase in children with type 2 diabetes. By examining the number of prescriptions for type 2 diabetes drugs taken by children ages 5–19 years, which doubled between 2002 and 2005.
Read More »New Groundbreaking Treatment for Diabetes Neuropathy a Success
Injecting patients with a DNA-binding protein may prevent diabetes-related nerve damage – known as diabetic neuropathy – particularly to the hands and feet.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.